MENU

Why these 4 ASX shares are ending the week in the red

In afternoon trade the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is on course to make it three successive days of gains and is higher by 0.3% to 5,814 points.

Four shares that haven’t been able to follow the market higher today are listed below. Here’s why they are ending the week in the red:

The Argosy Minerals Limited (ASX: AGY) share price has plunged 8% to 23.5 cents after emerging from its self-imposed suspension. Investors appear to be disappointed that the mineral exploration company was forced to reduce its $15 million placement price to 18 cents per share from 22 cents.

The Cann Group Ltd (ASX: CAN) share price has continued its poor run and is down a further 3.5% to $1.18. the brings the medicinal cannabis company’s week-to-date decline to almost 10% despite there being no news out if it. However, considering its shares have more than doubled in value in the last three months, this decline could be due to profit-taking.

The Change Financial Ltd (ASX: CCA) share price has fallen 3% to 76.5 cents. Like Cann, this fast-growing fintech company’s shares have been on a tear recently, which could mean today’s decline is related to traders taking profit. I have been impressed with Change Financial’s recent results and believe it could be a great buy and hold investment.

The Xenith IP Group Ltd (ASX: XIP) share price has fallen 30% to $1.17 after the intellectual property services company provided full-year EBITDA guidance that fell short of the market’s expectations. Due largely to issues with recent acquisitions, Xenith IP expects EBITDA to be between $18 million and $22 million in FY 2018.

Doe your portfolio need a lift? Then grab these hot stocks before they lift off.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro owns shares of ChimpChange Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.